Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHMI model safety and feasibility in Tanzanian adults
NCT04788862Completed
- Sponsor
- University of Oxford
- Start
- Jul 2022
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Open-label trial in malaria (2 arms), sponsored by University of Oxford. Primary endpoints: Occurrence of adverse events at 98 days, Development of parasitaemia at 28 days and 1 more. Started Jul 2022; status: completed.
02
Conditions
malaria
Beyond the preview
Go deeper on NCT04788862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788862.